Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study

Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study

Hyperuricemia is an established risk factor for cardiovascular disease, including atrial fibrillation (AF). The prevalence of hyperuricemia and its clinical significance in patients with already diagnosed AF remain unexplored. <b>Methods</b>: The Polish Atrial Fibrillation (POL-AF) regis...

Full description

Bibliographic Details
Main Authors: Marcin Wełnicki, Iwona Gorczyca, Wiktor Wójcik, Olga Jelonek, Małgorzata Maciorowska, Beata Uziębło-Życzkowska, Maciej Wójcik, Robert Błaszczyk, Renata Rajtar-Salwa, Tomasz Tokarek, Jacek Bil, Michał Wojewódzki, Anna Szpotowicz, Małgorzata Krzciuk, Monika Gawałko, Agnieszka Kapłon-Cieślicka, Anna Tomaszuk-Kazberuk, Anna Szyszkowska, Janusz Bednarski, Elwira Bakuła-Ostalska, Beata Wożakowska-Kapłon, Artur Mamcarz
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
hyperuricemia
atrial fibrillation
heart failure
left ventricular ejection fraction
Online Access:https://www.mdpi.com/2077-0383/10/9/1829

Internet

https://www.mdpi.com/2077-0383/10/9/1829

Similar Items